Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004934
Status:
COMPLETED
Last Update Posted:
2013-02-04
First Post:
2000-03-07
Brief Title:
Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB Stage III or Stage IV Invasive Ovarian Epithelial Fallopian Tube or Peritoneal Cancer
Sponsor:
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000067620
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| NCIC Clinical Trials Group | NETWORK |
| European Organisation for Research and Treatment of Cancer - EORTC | NETWORK |